Review
Published on 25 Nov 2024
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495283
- 322 views
Type at least 3 characters
6,716 articles
Articles
Original Research
Published on 25 Nov 2024
Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477146
- 400 views
Review
Published on 25 Nov 2024
From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1492050
- 203 views
Case Report
Published on 25 Nov 2024
Special immune-related adverse events and subsequent photodynamic therapy in tislelizumab treatment for esophageal cancer: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1497259
- 124 views
Original Research
Published on 25 Nov 2024
IAPP blocks anti-breast cancer function of CD8+T cells via targeting cuproptosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481129
- 324 views
Original Research
Published on 25 Nov 2024
Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481331
- 648 views
Original Research
Published on 25 Nov 2024
Exploring osteosarcoma based on the tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1423194
- 424 views
Review
Published on 25 Nov 2024
Stanniocalcin-1 in tumor immunity: acts via macrophages
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1510182
- 131 views
Original Research
Published on 25 Nov 2024
Integrating multi-omics techniques and in vitro experiments reveals that GLRX3 regulates the immune microenvironment and promotes hepatocellular carcinoma cell proliferation and invasion through iron metabolism pathways
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1496886
- 196 views
Original Research
Published on 25 Nov 2024
Unraveling impact and potential mechanisms of baseline pain on efficacy of immunotherapy in lung cancer patients: a retrospective and bioinformatic analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456150
- 144 views
Original Research
Accepted on 22 Nov 2024
Bibliometric analysis and visualization of the research on the relationship between RNA methylation and immune cell infiltration in tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477828
Perspective
Accepted on 22 Nov 2024
What immunology has to say about pesticide safety
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487805
Original Research
Accepted on 22 Nov 2024
NRF-1 Transcription Factor Regulates Expression of an Innate Immunity Checkpoint, CD47, During Melanomagenesis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495032
Original Research
Accepted on 22 Nov 2024
Development and validation of a novel immune-r elated pr ognostic model and the potential metastatic mechanism in synovial sar coma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1448464
Systematic Review
Accepted on 22 Nov 2024
Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454393
Review
Accepted on 22 Nov 2024
Long non-coding RNAs are involved in the crosstalk between cancerassociated fibroblasts and tumor cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1469918